Maria Ferraiuolo is a biologist experienced in Cancer Research, Viral Vector Production applied to vaccines development or gene therapy applications, and Clinical Research. She obtained her Master’s degree in 2014 and PhD degree in 2018. From 2012 to 2018 she worked at Regina Elena National Cancer Institute (IRE-IFO, Rome) in cancer research field, and in 2018 she moved to pharmaceutical environment becoming part of ReiThera’s team (Rome) until 2021, with the role of Senior process development scientist. Moved by an increasing interest in Clinical Research, she joined the CRO PRA Health Sciences’ team (Milan) acting as Site Activation Specialist since 2021.